1. Home
  2. GVA vs KRYS Comparison

GVA vs KRYS Comparison

Compare GVA & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GVA
  • KRYS
  • Stock Information
  • Founded
  • GVA 1922
  • KRYS 2015
  • Country
  • GVA United States
  • KRYS United States
  • Employees
  • GVA N/A
  • KRYS N/A
  • Industry
  • GVA Military/Government/Technical
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GVA Industrials
  • KRYS Health Care
  • Exchange
  • GVA Nasdaq
  • KRYS Nasdaq
  • Market Cap
  • GVA 4.1B
  • KRYS 4.3B
  • IPO Year
  • GVA 1990
  • KRYS 2017
  • Fundamental
  • Price
  • GVA $107.78
  • KRYS $147.70
  • Analyst Decision
  • GVA Strong Sell
  • KRYS Strong Buy
  • Analyst Count
  • GVA 1
  • KRYS 10
  • Target Price
  • GVA $76.00
  • KRYS $204.90
  • AVG Volume (30 Days)
  • GVA 654.5K
  • KRYS 385.5K
  • Earning Date
  • GVA 08-07-2025
  • KRYS 08-04-2025
  • Dividend Yield
  • GVA 0.48%
  • KRYS N/A
  • EPS Growth
  • GVA 70.18
  • KRYS 36.22
  • EPS
  • GVA 3.11
  • KRYS 4.91
  • Revenue
  • GVA $4,078,324,000.00
  • KRYS $359,205,000.00
  • Revenue This Year
  • GVA $12.76
  • KRYS $34.33
  • Revenue Next Year
  • GVA $9.12
  • KRYS $47.84
  • P/E Ratio
  • GVA $34.52
  • KRYS $30.30
  • Revenue Growth
  • GVA 7.17
  • KRYS 116.08
  • 52 Week Low
  • GVA $69.08
  • KRYS $122.80
  • 52 Week High
  • GVA $112.16
  • KRYS $207.84
  • Technical
  • Relative Strength Index (RSI)
  • GVA 59.66
  • KRYS 51.88
  • Support Level
  • GVA $109.40
  • KRYS $143.09
  • Resistance Level
  • GVA $112.16
  • KRYS $151.86
  • Average True Range (ATR)
  • GVA 1.96
  • KRYS 4.51
  • MACD
  • GVA -0.44
  • KRYS 0.32
  • Stochastic Oscillator
  • GVA 14.79
  • KRYS 69.24

About GVA Granite Construction Incorporated

Granite Construction Inc engages in the construction and development of various infrastructure projects on behalf of public and private clients in the United States. It focuses on heavy civil infrastructure projects, including roads, highways, transit facilities, airports, bridges, and other infrastructure projects. In addition, the company performs site preparation and infrastructure services for residential development, energy development, and other facilities. The majority of revenue is derived from the company's Construction operating segment, with the remainder derived from its Materials segment.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: